B

BioDelivery Sciences International Inc
F:BD5

Watchlist Manager
BioDelivery Sciences International Inc
F:BD5
Watchlist
Price: 5.05 EUR Market Closed
Market Cap: 521.3m EUR

Net Margin
BioDelivery Sciences International Inc

50.9%
Current
-3%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
50.9%
=
Net Income
84.9m
/
Revenue
166.7m

Net Margin Across Competitors

No Stocks Found

BioDelivery Sciences International Inc
Glance View

Market Cap
499.2m EUR
Industry
Pharmaceuticals

BioDelivery Sciences International, Inc. operates as a pharmaceutical company, which engages in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. The company is headquartered in Raleigh, North Carolina and currently employs 200 full-time employees. The company went IPO on 2002-06-25. The firm focuses on delivering therapies for individuals living with serious and debilitating chronic conditions. The Compnay builts a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA), drug-delivery technology to develop and commercialize new applications of therapies aimed at addressing important unmet medical needs. BEMA drug delivery technology consists of a small, bi-layered erodible polymer film for application to the buccal mucosa (the lining inside the cheek). The firm's product candidates includes BELBUCA (buprenorphine buccal film), CIII, for Chronic Pain; Symproic (naldemedine), for Opioid Induced Constipation and ONSOLIS (fentanyl buccal soluble film) for Breakthrough Cancer Pain.

BD5 Intrinsic Value
Not Available
B
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
50.9%
=
Net Income
84.9m
/
Revenue
166.7m
What is the Net Margin of BioDelivery Sciences International Inc?

Based on BioDelivery Sciences International Inc's most recent financial statements, the company has Net Margin of 50.9%.

Back to Top